ID Biomedical
Vancouver
About ID Biomedical
ID Biomedical Corporation develops and markets vaccine products. The company markets Fluviral, an injectable vaccine for influenza, as well as NeisVac-C for Meningococcal Group C disease in Canada. It also distributes NeisVac-C under license from Baxter Corporation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Phone: (604)431-9314
Canonical: https://fsome.com/organization/id-biomedical-3004709 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.